CRISPR-Cas9 human gene replacement and phenomic characterization in Caenorhabditis elegans to understand the functional conservation of human genes and decipher variants of uncertain significance

Autor: Joseph Liang, Kota Mizumoto, Catharine H. Rankin, Donald G. Moerman, Aaron D Loewen, Vinci Au, Troy A. McDiarmid
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Gene Dosage
Medicine (miscellaneous)
lcsh:Medicine
Sodium Chloride
Choice Behavior
Genome
0302 clinical medicine
Immunology and Microbiology (miscellaneous)
Genome editing
CRISPR-Associated Protein 9
CRISPR
Variants of uncertain significance
Phenomics
Exome
Caenorhabditis elegans
Conserved Sequence
Genes
Helminth

Gene Editing
Neurons
0303 health sciences
Chemotaxis
Humanization
3. Good health
Phenotype
Gene Targeting
CRISPR-Cas9
lcsh:RB1-214
Neuroscience (miscellaneous)
Computational biology
Biology
General Biochemistry
Genetics and Molecular Biology

Genome engineering
03 medical and health sciences
Genetic model
lcsh:Pathology
Animals
Humans
Resource Article
Amino Acid Sequence
Caenorhabditis elegans Proteins
Gene
030304 developmental biology
Whole genome sequencing
lcsh:R
PTEN Phosphohydrolase
Genetic Variation
biology.organism_classification
Dd
030104 developmental biology
Human genome
CRISPR-Cas Systems
Gene Deletion
030217 neurology & neurosurgery
Zdroj: Disease Models & Mechanisms, Vol 11, Iss 12 (2018)
Disease Models & Mechanisms
ISSN: 1754-8411
1754-8403
Popis: Our ability to sequence genomes has vastly surpassed our ability to interpret the genetic variation we discover. This presents a major challenge in the clinical setting, where the recent application of whole-exome and whole-genome sequencing has uncovered thousands of genetic variants of uncertain significance. Here, we present a strategy for targeted human gene replacement and phenomic characterization, based on CRISPR-Cas9 genome engineering in the genetic model organism Caenorhabditis elegans, that will facilitate assessment of the functional conservation of human genes and structure-function analysis of disease-associated variants with unprecedented precision. We validate our strategy by demonstrating that direct single-copy replacement of the C. elegans ortholog (daf-18) with the critical human disease-associated gene phosphatase and tensin homolog (PTEN) is sufficient to rescue multiple phenotypic abnormalities caused by complete deletion of daf-18, including complex chemosensory and mechanosensory impairments. In addition, we used our strategy to generate animals harboring a single copy of the known pathogenic lipid phosphatase inactive PTEN variant (PTEN-G129E), and showed that our automated in vivo phenotypic assays could accurately and efficiently classify this missense variant as loss of function. The integrated nature of the human transgenes allows for analysis of both homozygous and heterozygous variants and greatly facilitates high-throughput precision medicine drug screens. By combining genome engineering with rapid and automated phenotypic characterization, our strategy streamlines the identification of novel conserved gene functions in complex sensory and learning phenotypes that can be used as in vivo functional assays to decipher variants of uncertain significance.
Summary: Here, we provide a CRISPR-Cas9 human gene replacement and phenomic characterization strategy to directly replace Caenorhabditis elegans genes with their human orthologs for disease variant modeling and therapeutic screening.
Databáze: OpenAIRE